Health economic models: a question of balance - summary of an open discussion on the pharmacoeconomic evaluation of non-steroidal anti-inflammatory drugs

Research output: Contribution to journalArticlepeer-review

Abstract

Pharmacoeconomics and pharmacoeconomic models are increasingly being used to guide health care decisions In designing and using these models, an appropriate balance must be struck between scientific rigour and model transparency. It is therefore important to consider carefully how the various model components, such as model perspective, internal and external validity, and choice of comparators and outcomes, should be integrated into the model. These factors are discussed in relation to the pharmacoeconomic evaluation of non-steroidal anti-inflammatory drugs.

Original languageEnglish
Pages (from-to)29-32
Number of pages4
JournalRheumatology
Volume39
Issue number2
Publication statusPublished - Dec 2000

Keywords

  • pharmacoeconomics
  • NSAIDs
  • health outcomes
  • QUALITY-OF-LIFE
  • RHEUMATOID-ARTHRITIS
  • MEDICAL LITERATURE
  • CLINICAL-PRACTICE
  • USERS GUIDES
  • OSTEOARTHRITIS
  • ARTICLE

Cite this